Director in Sensient (NYSE: SXT) defers fees into deferred stock

Rhea-AI Filing Summary

Sensient Technologies director Joseph Carleone received 422.547 shares of deferred stock as a grant tied to director fee deferrals. This deferred stock converts into common stock on a one-for-one basis and is issued after his service as a director ends.

Following the grant, his reported deferred stock holdings total 23,780.400 shares. A separate holding entry shows 22,551.313 shares of common stock held directly, which includes restricted stock under the company’s 2017 Stock Plan and shares accumulated through a dividend reinvestment plan.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider Carleone Joseph

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Deferred Stock	422.547	$0.00	--
holding	Common Stock	--	--	--

Holdings After Transaction: Deferred Stock — 23,780.4 shares (Direct); Common Stock — 22,551.313 shares (Direct)

Footnotes (1)

1. Includes shares of restricted stock held under Issuer's 2017 Stock Plan, as amended and restated, and shares held in a dividend reinvestment plan. Deferred stock converts to common stock on a one-for-one basis. Deferral of director fees under Issuer's Directors' Deferred Compensation Plan. Shares of common stock will be issued upon termination of reporting person's service as a director of the Issuer.

Key Figures

Deferred stock grant: 422.547 shares Deferred stock holdings after grant: 23,780.400 shares Direct common stock holdings: 22,551.313 shares

3 metrics

Deferred stock grant 422.547 shares Director fee deferral grant on deferred stock

Deferred stock holdings after grant 23,780.400 shares Total deferred stock following the award

Direct common stock holdings 22,551.313 shares Common stock held directly after reported transactions

Key Terms

Deferred Stock, Directors' Deferred Compensation Plan, dividend reinvestment plan, restricted stock

4 terms

Deferred Stock financial

"Deferred stock converts to common stock on a one-for-one basis."

Directors' Deferred Compensation Plan financial

"Deferral of director fees under Issuer's Directors' Deferred Compensation Plan."

dividend reinvestment plan financial

"and shares held in a dividend reinvestment plan."

A dividend reinvestment plan lets shareholders automatically use cash dividends to buy more shares of the same company instead of receiving the money. It matters to investors because it turns regular payouts into a steady way to grow ownership and take advantage of compound returns—like having your savings automatically buy additional slices of a pie over time—while often reducing transaction costs and smoothing purchase timing.

restricted stock financial

"Includes shares of restricted stock held under Issuer's 2017 Stock Plan."

Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Carleone Joseph

(Last) (First) (Middle)

777 EAST WISCONSIN AVENUE

(Street)

MILWAUKEE WISCONSIN 53202

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
SENSIENT TECHNOLOGIES CORP [ SXT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/31/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock								22,551.313(1)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Deferred Stock	(2)	03/31/2026		A(3)		422.547		(4)	(4)	Common Stock	422.547	$0	23,780.4	D

Explanation of Responses:

1. Includes shares of restricted stock held under Issuer's 2017 Stock Plan, as amended and restated, and shares held in a dividend reinvestment plan.

2. Deferred stock converts to common stock on a one-for-one basis.

3. Deferral of director fees under Issuer's Directors' Deferred Compensation Plan.

4. Shares of common stock will be issued upon termination of reporting person's service as a director of the Issuer.

	/s/ John J. Manning, Attorney-in-Fact for Dr. Carleone	04/01/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did Sensient Technologies (SXT) director Joseph Carleone report in this Form 4?

He reported a grant of 422.547 shares of deferred stock linked to director fee deferrals. This award increases his deferred stock balance and reflects compensation rather than an open-market stock purchase or sale.

How many deferred stock shares does Joseph Carleone hold after this Sensient (SXT) transaction?

After the grant, he holds 23,780.400 shares of deferred stock. These deferred stock units are designed to convert into common stock on a one-for-one basis when his service as a director of Sensient Technologies ends.

Does the Form 4 show any open-market buying or selling of Sensient (SXT) shares?

No open-market buys or sells are reported. The filing describes a grant of deferred stock associated with director fee deferrals and a separate holding entry for common stock, rather than discretionary market transactions.

How and when does the deferred stock reported by Sensient (SXT) convert into common stock?

The deferred stock converts into common stock on a one-for-one basis. According to the disclosure, the shares of common stock will be issued when Joseph Carleone’s service as a director of Sensient Technologies ends.

What does the Form 4 say about Joseph Carleone’s direct common stock holdings in Sensient (SXT)?

A holding entry shows 22,551.313 shares of common stock held directly. This amount includes restricted stock granted under Sensient’s 2017 Stock Plan and shares accumulated through a dividend reinvestment plan, as described in the filing’s footnotes.